{"ticker": {"uuid": "acc77fe3-1c93-46f3-a9a1-1d4d33093d4e", "symbol": "4502", "name": "Takeda Pharmaceutical Company Limited", "exchange": "JPX", "country": "JP", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "TAK News Today | Why did Takeda Pharmaceutical stock go down today? $TAK", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTFBLTzhxa0NkWjNOVUZiVE9GR01aUzlsRXpIUDBWRU8tSDZJTV92TG1mbUx6OGtxNEdsLXhJZ29RempkLU9vWlZWSmw2UkNPd0ZHLVota2JkaXpiZ2hF?oc=5", "source_name": "MarketBeat", "published_at": "2026-08-02T07:00:00+00:00", "published_display": "02 Aug 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Ready to Resume Top-Line Growth With Refreshed Late-Stage Pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOZjNoQ3NiTmRabmVVMEtnb2FpbFBzZXAzTTI4bTk4RVg2Rlh5Q2JwT3F4bTdaQVM4b3VBbVlyUjdmTDNOUVRHQjZaWGtoSVhoOXc4R1RIWExJV3ZJQndaUDBUSUIyWXlKZkdTd3o2UlNkWXQxWW1tTHljaHpDMF9UbThjNnhLZjh1eEtGZUE1TzA1N0cwdmZUTnRrclJVVjNCbjVWWkdnMkNwZnk5N1JjaV9iVUhzSVhwQmZtWDJQcG1tZEE?oc=5", "source_name": "Morningstar", "published_at": "2026-07-31T12:02:22+00:00", "published_display": "31 Jul 2026 12:02", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda (TSE:4502) Stock Struggles To Convert Revenue Growth Into Lasting Profit", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-31T11:46:13+00:00", "published_display": "31 Jul 2026 11:46", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Can Takeda Pharmaceutical (TSE:4502) Trade At A Discount On New Phase 3 Psoriasis Data?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-27T13:27:46+00:00", "published_display": "27 Jul 2026 13:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda (TSE:4502) Stock Looks Below Fair Value While Broader Checks Stay Mixed", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxOdzhwRGktby1DQXNpUlgwQ09vcDM3ZFA0eGtkUWp4UGhTZ1ZsZ1hmRkRxU19CSzlIVG56cFFTZVBuZWtfSXpxbml0SHpWMlJtTGdIakxRd1lPZzYzUDZDNEp6aTRjT0daek1jbE9ROGRuZHg5ZUxkMmlBRW5KSUx6MFBn?oc=5", "source_name": "Yahoo! Finance Canada", "published_at": "2026-07-26T23:12:14+00:00", "published_display": "26 Jul 2026 23:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How New Phase 3 Psoriasis Data For Zasocitinib At Takeda Pharmaceutical (TSE:4502) Has Changed Its Investment Story", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPbWRDUGZXQWJrNU5TWHc4dFptUVFQUDJ1QlFlUU00d3J2SnAwYlNQSFhXcGhoMXN3SUNMNGVmeTJpTWtfMGI3SDBSM1dWWXZUTk02MXBGTl9GVmhLSUZnWU5ZendtTG1hNkstSGpkS3dIUlZZeWtxRGFzd2t2RmM3c2luNkxiTGl4NGV5c0puTkdpaHZjRFE3cEdsQQ?oc=5", "source_name": "Market source", "published_at": "2026-07-26T07:00:00+00:00", "published_display": "26 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Bull Case For Takeda Pharmaceutical (TSE:4502) Could Change Following New Zasocitinib Phase 3 Psoriasis Data", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-25T14:27:37+00:00", "published_display": "25 Jul 2026 14:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TAK|Takeda Pharmaceutical Co Ltd|Price:17.090|Chg%:-0.155", "summary": "", "url": "https://news.google.com/rss/articles/CBMiY0FVX3lxTFAyZzJFcWdncWs1RFVmLUJSazRuNVlxMEtQMHZXYXRESUhfSVZZakd6bU1XQ3NrVnRWNE1sR1BoM0pWZlZyYXh5U2tDREhzSkN1OV9oU3RIYkNURkhDUWstcnNKUQ?oc=5", "source_name": "TradingKey", "published_at": "2026-07-24T13:40:25+00:00", "published_display": "24 Jul 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical (TSE:4502) After Psoriasis Data And FDA Filing Plans Still Looks Undervalued", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-18T10:30:21+00:00", "published_display": "18 Jul 2026 10:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical (TSE:4502) Is Up 5.3% After New Insilico AI Drug Discovery Deal - Has The Bull Case Changed?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda (TSE:4502) Stock Still Looks Slightly Undervalued Overall", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda\u2019s New AI Drug Discovery Deal With Insilico Might Change The Case For Investing In Takeda Pharmaceutical (TSE:4502)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxQaUUxUlJUcFNJZEdSUHJET2NDYVlMb0dDZGQyYU1SNjRkLVQ0cTlXVkhlb1EzM3JRREN0WnVBcWFpSkpkLU5VR2NwbVVLX3d0aTFwVXU5X0RBd2l6R3pVNUs5ZzBXZ2Q5azhIeW13Z2dnemQ1MjZYNlZUNkhOOTJJTmVJMkVFYUZ6Uk9vNEx4emZKWTFx?oc=5", "source_name": "Market source", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Takeda Pharmaceutical Company Limited (TAK) Stock Positioned for Growth After Strong LATITUDE Atlas Study Data?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOMnlTVE96dXFleVkwdWRIQlhkc1VHWWhjSG1qbmVhVVRjYm83NzBOaWczNHZJMm5fQjRoY21SRXc5V1BKalk1RHhocXZJU1BhdmhwVUUtVTUybDNUUFd5MzdjSjZIVVNwQ3hwQ3p5WGgyeGtBZ2Nad2laTXpVM3YxQ0s5bjhhemJlVUZwMFdZS25Sak52cTAzd0d2S1YwWjZBVVFHRw?oc=5", "source_name": "Market source", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda sees return to growth within three years, new CEO says", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE5EWGFLV3ZzTlBkQWxvRjVmSlpaNm9sMGpZSk54Z19RcXkxd1Y2aHBzUHQ2cDhqR1AxZjYyd2gzMG1oLXhVWU1KeHhVVDhyb2hZTkdqZEo4eGNmYXRXWWFmZTNMeWJSUGZybkxFTm0wWk43UHE5QnM1bC1DaUx6VEU?oc=5", "source_name": "The Japan Times", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda's AI-crafted psoriasis pill tops Bristol Myers' Sotyktu in head-to-head trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNSjVZb2pNODVWN1BXbFp6Q2FmUmZnbGNKdFUtdmpfX0J1RDBRZk9Db0xjZWdyTzkwTW1Lbm9nT1dkMnJwNkZoTjRkQ19QWHZReXFCdFAzM0oycHlpRzJ5NG11c1VxUnJJZ3BtOW9ZNmtxNEtUVVY4VVpJSk1aem44RzNCeVVoMXdRQmtMTXhfMnVRSk9rcDBuLXAtelFRMTl0R1VaNkQ3RElwUl82OFNIV2t4eTYxZWVZYXItUjdYOUdSOEdiMGhlbkg5VTRDbXhEWHVKbWtZcHNZMXNUOTVPMmRwOXdqQQ?oc=5", "source_name": "Reuters", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical Co Ltd (TAK) Shares Fall 4.8% -- GF Value Says Still Overvalued", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQRl9mR205aVc5TldjTkY2TGU2alo1ZFJXa256aVA2Rmk0b3VwYW5SUG1NeTNGWlY0VG1iQ1M1bGwzbWpJakJvRTZrbUd3dzVCNlNDcTZlTHp2bDEtM0NJbkItYktWVF8zM3oyZVd4X3B5TE82MlJuQy02dmJ0UVZfR19TUURucUVyblpxUWF0aHViUHlRa1lfLUV4aW5kbmtLNWRzNEVFN3NMT0gyMlVJcW4yVDlYRmtqNUpJdnBES2JSLW9UaER6NQ?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MS-Japan Index Earning Revision (May): Mitsubishi, Takeda Pharmaceutical, Mitsubishi UFJ Financial", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQa1FRd2xfNWVpaTZ1SHhCdTJybVNTOVJWOVkwQzBvdFAwQVR3WTdTSnJwLTY2SndSRHl5eGVUSmxydXdaYy1uR2ZlUV9zOEg2R2RhVXFTRWN1NFdOLXprZDdpWEpsR1pHSENaX2RmdVl2QnNZdmVxeFBPaTV6VGoxQ2RtdW9fSnptb0wxaS12TGtpT3lDWWl2d0tOTGtidTZfemtxZURtSkg1UnVHX3ZiQUJDSEF4ODdJYktsenl0eDhxdFMzZUFaLQ?oc=5", "source_name": "Smartkarma", "published_at": "2026-05-31T07:00:00+00:00", "published_display": "31 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical (TSE:4502) Valuation Check As Short Term Weakness Meets Longer Term Returns", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPZk1Na2F1bFYwUE9hR2FkVnhjaGZvbEVLUWZYblNlalFoNzE3ODBGREZJSEQ5dVo4MkhwMTQyemw0d0djaF9ZQ3BYVkZ6cldVWU9JLXRld0d3ay0yMTZneDA2Z2RhMmJpV3d3UmJDVE9reXRjVl9UV2F5elY4Wlk5TmJZNkdPN25WUjNpRUJkM2phb2VMWWlsYkwwUDJxVm9PUGV3VEhGY2szbm1FOWc?oc=5", "source_name": "Market source", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda (TAK) plans FY2025 IFRS earnings revision after AMITIZA antitrust verdict", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPQWlYWXNHam5saERTLWVpOWItNldKdkJJaXJRVmI3Q0RYQmZSOGhPMWl4eV9obEVSTHd4N0lVLVJodVJDSkROUFRkMnljU3BmWFhyaGZkOVFyLU5DRVVNLXJOUG1kd3pvMjBOcm1FNzNSX1oxQTVMc21XN1F4ZExlZktVWVdibHdTWW9uaTJucVUtVEdyeW5OVDQxaWpHODgzcC11UjRrZzJPZmtESWFheUpwZVpZWmNpTmxvOURXZXQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical : Continuation of the Stock Compensation Plan for Directors and the Stock Grant System for Company Management in Japan in 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNNHZOdThzN0F2YkNLZ3lrNE9OT3luR2ZZV1MzcFlxODB0ODFZZXIzVXl0MVJNRWVyZEVLdFA3Xy1CRXYxQzFXb1NfZUx2ZldES19ObzlIdzZOajVxaHNMenRMYXA2YW5JbU82bkwtdXBVR2ZRZVA1WVJHdmJTWDJhdXh0SGlsMGJfVkZaaF9XNzAzYUQ1LUN4RzNNMGlNU3NsMjgyVEtxNHVXMUpKcTFTdUdBRkdaM1hnMWgtWFdueWZHelZkQVRjdVFiTV9uZFA0dm9NYXltSndkcW1KSjY4eWU1NkFtZw?oc=5", "source_name": "marketscreener.com", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical (TSE:4502) Valuation Check After Recent Share Price Pullback", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQeGp1cEpfNUx4ZjE5Ml9ONWFydUZqV0d4VTlvLWstc1U5YUZIcHFZcTAwbThPTHBxY2liWmVHbmtZVXZiVjl5NldjWUlROUY2WVJiTmJiQms1YzF1X1ZiNjd5NUtacTc1Yk0wc3VuM1g3NjMxdjZOblFfTGlzZWNKUDJiM1E0S1Z1YTZ4dDdJSkdhbjRESmNPOFp5RGJtbERkTTdDWTVWdkxUVTN0MVE?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Takeda Pharmaceutical Company Limited (TAK) One of the Best Japanese Stocks Amid Restructuring Drive?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQRkFWZ3o4c21ET2tVMzVGNDFhVS1OZnhIZU5uOEh5akxTT2JuV0ZvaEtLRl9DNHZBS1VwOVZWNlBnZEdYOVYta0ZnbmNmaUhoVDFURjJqT1QyZnBPWjJzenlmUnc5dGhyeW5NUWN0V1JyTE12WEtaVEluUm8wQ1FwLUdXZVFfU1JFTEhha0lmcXcxaF9hd19jcTZmSzY3N1F5cWlPal9jbGNIajNhbFQ4?oc=5", "source_name": "Market source", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNckpfeDdTSDBxVTFueWdHZHRya2tPcDVKdWxJR005c0Q1MjdNRXE0cG1OalM2LW1yMUxuekZXOHhlRFcydVlibUgwVnNSRkdQd2lRTUhhR0ItVk5ub2loSGFzanNwX1BLLXlpZklYc3RXTWJodDdWNU0wLTd3dXBPOXBCV3VhdGZSb2FzTzk2SmNLTkRfcFJOV3E2YnJwOEFzdjRMQkNROHlxOGwxRVRR?oc=5", "source_name": "Market source", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Takeda Pharmaceutical (TSE:4502) Valuation After Mixed Pipeline News On DNL593 And Zasocitinib", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQU1VkMlNwTmlsYkQ2X3lrWDRrQ2JQQU1jdERabHhCVHZhcVBVNGpnUHJ5dWdJVzVTMXZVSUVDaTJBUExQRkZOSS1ZWjNOTHBqMDM5Y3hGMTJES3AwdU9yU1FQejlRYmI2bGtpNHdVLVZPOEptWGF0d3VLM09CMzFvZTNoSzJHdjc4Z3RVZTZjRlJHQmliVE9xZGV0cGZydzhVRW5uMnlXUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-08T07:00:00+00:00", "published_display": "08 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical Company Limited: Takeda Announces Next Steps in its Transformation to Strengthen Competitiveness and Accelerate Future Growth Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgJBVV95cUxQVlhuOWMyU3MybTdKNkN4R0E2WWx5dVZZa3VCSHNzVW9QUHg1b1E3Z3VPNDhWVjJGaXZmeXV5cVk1dnJTVHlhR25pcl9XN2hzdlF0ekJmd0J2Y2duMFhhRVBlSTEzRjVIem51eTVsVkhYcC1MTnhUeFI0M0xFMUpXaXlHLUd0R0ZBWDhiQ3J0UktERDF2bjQxTnN3V1E3VFBIeVBUbmtYQlBsMVBzQmtGYmRKS3JNUUpGenB0d01KY3ZMX2ctcnZkX2FsMi13eXMwMnd3N3loSWtsUjRoZVhaUDBRbXpCYlc2X0cyU2dpSkVXME5RZUN1QTk3WHhhOGtlNWlMZWswQXJNVVBFUzVJbXhNOUtaTXNYaVB1SGZQVS1CM3pxd19WdlU4RWtPRHVjb0E?oc=5", "source_name": "TradingView", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Takeda Pharmaceutical Company Limited (TAK) One of the Best Healthcare Stocks to Buy for 2026?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxPV2EwUkxKSVZNaEJLQ0o0NHFHdFZmQ29LTmt1NklBdnVFTHVueHZRTWRTSktZSk1BM1l6LS1sa1RTTXNnOEYtSUcyZ2JBU1V5a0pjRkRiOF9iN1hWNjRqOFpPalRTN0cydVNfbVM1NnB3MERnYmJWOFFKcmM4eE9aMzBabV9mTGgtUUN0dHpTWXM?oc=5", "source_name": "Market source", "published_at": "2026-01-31T08:00:00+00:00", "published_display": "31 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Takeda Pharmaceutical (TSE:4502) After Recent Pipeline Progress And Share Price Moves", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNc0RhajBSeDY4NDA1N2NqenA4cHBWRHE5Y3ZPWXNSdkplT3ZXNkJFRjZjLW1oX0FWNGZ1Z2VSWXpHYk9ISVpVMXozT1ZuZHRoNHFQaDhRNWYxTG4tUVlCdlJpOGM4RGZyRnhPMlAzMzFPUGVFYWdDUkxFMGNUbU5hQ1dJRnR6MlpiamNwSTdOUQ?oc=5", "source_name": "Market source", "published_at": "2026-01-21T08:00:00+00:00", "published_display": "21 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda: Lack Of Realistic Upside In Japanese Pharma (NYSE:TAK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPckc3aUR3TTRPMjVnQkFKRmxNRVZTQk5XdG41T0tZZnZnaDNERENKemd4dmNpRFhBU1dycV96MTQxVzBidkYyWTlSamVmSmhBQ3FGVGRkY0p2MndhT0Q4UXMwSThfNDBLWTJyWGd2akZZRUNHZGdFUFhoS3pqRGZ5cDFvVVQ5VmE2bHlTemIxcWM5VXhHMWc?oc=5", "source_name": "Seeking Alpha", "published_at": "2025-12-11T08:00:00+00:00", "published_display": "11 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China's Innovent signs cancer therapy deal with Japan's Takeda", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxPWER1VnZpYThnbk1ETFl4TmZwUFZVT2xDTEM1YUNKZDNlTXF4eVlsaFotczliNF9IM2xtNXkzUUgxM2NMcU9xRXNYRGQ5VldvdnJSb09GR2I0N0JCdnU5UTBsYi0tUmcxWGEySFdWZ2lwekRWejZ2Z0o0X2FRSDI0bjJBSERxbjJoQ0tQR3N3TlAyNDJYNEw2ZGFMVHlVamhIQlByZjU0RVQ4Y3prV0hyRVVOdDZVdzhwODRNbEtZYTd2aW8zLWpYeUItbXVFOXF5NFlPYmdVRGl6TF9t?oc=5", "source_name": "Reuters", "published_at": "2025-10-21T07:00:00+00:00", "published_display": "21 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "US biotech Nabla Bio, Japan's Takeda expand AI drug design partnership", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxNWG4zbm9ZM2ZwcGNoSHU5WHFuaUJzNVM2X0JiMFRlRlVMZUNXWWJpajFFVlJURl9meEhKOXBQTDAyQXNGeGk0NEJzX0plX0dFY2pTa2JyN1EtWmxyVG1zc2lKQ2g0TEMwdlZHSGFmbGJLU3dDcUJ0U25qcFkwNFY3elVBMWhkXzlqUmhqNWJCLTY4T0ZxRFd6di1DT1BneV9RM3FHdy1mUms3eElaT0FKSUlwTWdieXFDNDM1NUNTRlpKZDZvaXNsLU4zQ3pVcjZ5RmFKYk5vOA?oc=5", "source_name": "Reuters", "published_at": "2025-10-14T07:00:00+00:00", "published_display": "14 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Japan's Takeda weighs India for global trials to speed up drug launches", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxPbE41eFpTVmEzd2thU0c4Z20zT2lHc1RNMzZiWGlFa3JZNGZuTkdNZi1GZzh5T1pvbjNPTU82dExZczlFUGhNQ3Nmb1MtVTNXa0R6d003TUc1M2pqTWdkcTNGb3AxOHFVSEYzMldyQTVEYmg5bVVSRWhCVVpMYkE4YUpOMVptTEYtWUFrWkdPVDl2TTNOU1ZPRWVVeFFsalpjbHNmemZTZXFzVWJaYkI1UTU4dlp4bjgtOVBSTi1lN3pfbEJtNjVoTTRYVldqUTBH?oc=5", "source_name": "Reuters", "published_at": "2025-08-21T07:00:00+00:00", "published_display": "21 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharm (TAK) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUkFVX3lxTE1UaEZGVUlGS09USng0czlWN3ZkYlVrMWZQd3hxeFk3YmpSODNmM1B5RmZ3TUpuRmgxM0wxdm1LbjlCN3BpbmMzS1F4NTFSYVZibnc?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T01:22:22+00:00", "published_display": "25 Apr 2025 01:22", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Japan's Takeda announces share buyback as profit climbs", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYkFVX3lxTE5jMk5YRTA1NmNQQmVYUTBoOE9JcExjRms0ZDlaNldUYTl5NlNkUHZVaGZ3SmQtS3ZzaWJBbVgtSGM1NGdnc05QR3BGV3VrWkVEb3g0X1c3N0hGX2N0QmY2MGlR?oc=5", "source_name": "nippon.com", "published_at": "2021-10-28T07:00:00+00:00", "published_display": "28 Oct 2021 07:00", "sentiment": "positive", "sentiment_pct": 78, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "TAK News Today | Why did Takeda Pharmaceutical stock go down today? $TAK", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTFBLTzhxa0NkWjNOVUZiVE9GR01aUzlsRXpIUDBWRU8tSDZJTV92TG1mbUx6OGtxNEdsLXhJZ29RempkLU9vWlZWSmw2UkNPd0ZHLVota2JkaXpiZ2hF?oc=5", "source_name": "MarketBeat", "published_at": "2026-08-02T07:00:00+00:00", "published_display": "02 Aug 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Ready to Resume Top-Line Growth With Refreshed Late-Stage Pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOZjNoQ3NiTmRabmVVMEtnb2FpbFBzZXAzTTI4bTk4RVg2Rlh5Q2JwT3F4bTdaQVM4b3VBbVlyUjdmTDNOUVRHQjZaWGtoSVhoOXc4R1RIWExJV3ZJQndaUDBUSUIyWXlKZkdTd3o2UlNkWXQxWW1tTHljaHpDMF9UbThjNnhLZjh1eEtGZUE1TzA1N0cwdmZUTnRrclJVVjNCbjVWWkdnMkNwZnk5N1JjaV9iVUhzSVhwQmZtWDJQcG1tZEE?oc=5", "source_name": "Morningstar", "published_at": "2026-07-31T12:02:22+00:00", "published_display": "31 Jul 2026 12:02", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda (TSE:4502) Stock Struggles To Convert Revenue Growth Into Lasting Profit", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-31T11:46:13+00:00", "published_display": "31 Jul 2026 11:46", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Can Takeda Pharmaceutical (TSE:4502) Trade At A Discount On New Phase 3 Psoriasis Data?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-27T13:27:46+00:00", "published_display": "27 Jul 2026 13:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda (TSE:4502) Stock Looks Below Fair Value While Broader Checks Stay Mixed", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxOdzhwRGktby1DQXNpUlgwQ09vcDM3ZFA0eGtkUWp4UGhTZ1ZsZ1hmRkRxU19CSzlIVG56cFFTZVBuZWtfSXpxbml0SHpWMlJtTGdIakxRd1lPZzYzUDZDNEp6aTRjT0daek1jbE9ROGRuZHg5ZUxkMmlBRW5KSUx6MFBn?oc=5", "source_name": "Yahoo! Finance Canada", "published_at": "2026-07-26T23:12:14+00:00", "published_display": "26 Jul 2026 23:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How New Phase 3 Psoriasis Data For Zasocitinib At Takeda Pharmaceutical (TSE:4502) Has Changed Its Investment Story", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPbWRDUGZXQWJrNU5TWHc4dFptUVFQUDJ1QlFlUU00d3J2SnAwYlNQSFhXcGhoMXN3SUNMNGVmeTJpTWtfMGI3SDBSM1dWWXZUTk02MXBGTl9GVmhLSUZnWU5ZendtTG1hNkstSGpkS3dIUlZZeWtxRGFzd2t2RmM3c2luNkxiTGl4NGV5c0puTkdpaHZjRFE3cEdsQQ?oc=5", "source_name": "Market source", "published_at": "2026-07-26T07:00:00+00:00", "published_display": "26 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Bull Case For Takeda Pharmaceutical (TSE:4502) Could Change Following New Zasocitinib Phase 3 Psoriasis Data", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8AFBVV95cUxQdGV3V1B1aTNiZ2RpS0NuWGJqeVpWTHJHcTRnYzRQMTg2ODNMdnN4aUVLWUJaY3VyTmp3NUxpcjl2QnF5ZVhJR1Y1ZWhsMlRhRmFhZEtKcGJDN2hOZEc4RXRuMEFIUU95NGg2aHBpMl9sVm82M3Y0VXVxMFpmN2hkMHJ0RkpIQUotY2ZkRkdkN3c1dWJya3Q2VldwWjZLbFV1eUNKLTk3LVZNWTlHMk9uNHpFN0Q3d1VtYzkza3VTZ0VUMm9Lc2VXbUt0MUpab3RhM2Y2SENkbFJnODJnY29uYjNIWkt0Y29yT1RZMXd6RjbSAfYBQVVfeXFMTmJFV2owdFE5VnZYNlFIcFpsUkFjWWdTMkNhbnc5NWNGWW9hQi1aYTNRN3FkTjNTMkduUFRqZXFrQlI5QXg5WW12SVZvTnlLbW0yTDFOMl9zS091cWVCVllDdFUyQnNVWmxaTUs2aXdnLUFIYjNGRnZkak85QUVtTFMwdEx4cE9HZWxZcnZGTGhUbTNnRDdGUDFMV08tc3BDXzJCaEgxQk5TZXRGdFZSdFdlYkxYa0xXeG5PWGFCNnNrM081NXR6U1NMV0RnaVFHaWNJSEpPUk1Rd3VLMWRWR21PRGlRMk9nUGlIRGlPb2p0M0ZySWhR?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-25T14:27:37+00:00", "published_display": "25 Jul 2026 14:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TAK|Takeda Pharmaceutical Co Ltd|Price:17.090|Chg%:-0.155", "summary": "", "url": "https://news.google.com/rss/articles/CBMiY0FVX3lxTFAyZzJFcWdncWs1RFVmLUJSazRuNVlxMEtQMHZXYXRESUhfSVZZakd6bU1XQ3NrVnRWNE1sR1BoM0pWZlZyYXh5U2tDREhzSkN1OV9oU3RIYkNURkhDUWstcnNKUQ?oc=5", "source_name": "TradingKey", "published_at": "2026-07-24T13:40:25+00:00", "published_display": "24 Jul 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical (TSE:4502) After Psoriasis Data And FDA Filing Plans Still Looks Undervalued", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-18T10:30:21+00:00", "published_display": "18 Jul 2026 10:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical (TSE:4502) Is Up 5.3% After New Insilico AI Drug Discovery Deal - Has The Bull Case Changed?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda (TSE:4502) Stock Still Looks Slightly Undervalued Overall", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda\u2019s New AI Drug Discovery Deal With Insilico Might Change The Case For Investing In Takeda Pharmaceutical (TSE:4502)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxQaUUxUlJUcFNJZEdSUHJET2NDYVlMb0dDZGQyYU1SNjRkLVQ0cTlXVkhlb1EzM3JRREN0WnVBcWFpSkpkLU5VR2NwbVVLX3d0aTFwVXU5X0RBd2l6R3pVNUs5ZzBXZ2Q5azhIeW13Z2dnemQ1MjZYNlZUNkhOOTJJTmVJMkVFYUZ6Uk9vNEx4emZKWTFx?oc=5", "source_name": "Market source", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Takeda Pharmaceutical Company Limited (TAK) Stock Positioned for Growth After Strong LATITUDE Atlas Study Data?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOMnlTVE96dXFleVkwdWRIQlhkc1VHWWhjSG1qbmVhVVRjYm83NzBOaWczNHZJMm5fQjRoY21SRXc5V1BKalk1RHhocXZJU1BhdmhwVUUtVTUybDNUUFd5MzdjSjZIVVNwQ3hwQ3p5WGgyeGtBZ2Nad2laTXpVM3YxQ0s5bjhhemJlVUZwMFdZS25Sak52cTAzd0d2S1YwWjZBVVFHRw?oc=5", "source_name": "Market source", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda sees return to growth within three years, new CEO says", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE5EWGFLV3ZzTlBkQWxvRjVmSlpaNm9sMGpZSk54Z19RcXkxd1Y2aHBzUHQ2cDhqR1AxZjYyd2gzMG1oLXhVWU1KeHhVVDhyb2hZTkdqZEo4eGNmYXRXWWFmZTNMeWJSUGZybkxFTm0wWk43UHE5QnM1bC1DaUx6VEU?oc=5", "source_name": "The Japan Times", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda's AI-crafted psoriasis pill tops Bristol Myers' Sotyktu in head-to-head trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNSjVZb2pNODVWN1BXbFp6Q2FmUmZnbGNKdFUtdmpfX0J1RDBRZk9Db0xjZWdyTzkwTW1Lbm9nT1dkMnJwNkZoTjRkQ19QWHZReXFCdFAzM0oycHlpRzJ5NG11c1VxUnJJZ3BtOW9ZNmtxNEtUVVY4VVpJSk1aem44RzNCeVVoMXdRQmtMTXhfMnVRSk9rcDBuLXAtelFRMTl0R1VaNkQ3RElwUl82OFNIV2t4eTYxZWVZYXItUjdYOUdSOEdiMGhlbkg5VTRDbXhEWHVKbWtZcHNZMXNUOTVPMmRwOXdqQQ?oc=5", "source_name": "Reuters", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical Co Ltd (TAK) Shares Fall 4.8% -- GF Value Says Still Overvalued", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQRl9mR205aVc5TldjTkY2TGU2alo1ZFJXa256aVA2Rmk0b3VwYW5SUG1NeTNGWlY0VG1iQ1M1bGwzbWpJakJvRTZrbUd3dzVCNlNDcTZlTHp2bDEtM0NJbkItYktWVF8zM3oyZVd4X3B5TE82MlJuQy02dmJ0UVZfR19TUURucUVyblpxUWF0aHViUHlRa1lfLUV4aW5kbmtLNWRzNEVFN3NMT0gyMlVJcW4yVDlYRmtqNUpJdnBES2JSLW9UaER6NQ?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MS-Japan Index Earning Revision (May): Mitsubishi, Takeda Pharmaceutical, Mitsubishi UFJ Financial", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQa1FRd2xfNWVpaTZ1SHhCdTJybVNTOVJWOVkwQzBvdFAwQVR3WTdTSnJwLTY2SndSRHl5eGVUSmxydXdaYy1uR2ZlUV9zOEg2R2RhVXFTRWN1NFdOLXprZDdpWEpsR1pHSENaX2RmdVl2QnNZdmVxeFBPaTV6VGoxQ2RtdW9fSnptb0wxaS12TGtpT3lDWWl2d0tOTGtidTZfemtxZURtSkg1UnVHX3ZiQUJDSEF4ODdJYktsenl0eDhxdFMzZUFaLQ?oc=5", "source_name": "Smartkarma", "published_at": "2026-05-31T07:00:00+00:00", "published_display": "31 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical (TSE:4502) Valuation Check As Short Term Weakness Meets Longer Term Returns", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPZk1Na2F1bFYwUE9hR2FkVnhjaGZvbEVLUWZYblNlalFoNzE3ODBGREZJSEQ5dVo4MkhwMTQyemw0d0djaF9ZQ3BYVkZ6cldVWU9JLXRld0d3ay0yMTZneDA2Z2RhMmJpV3d3UmJDVE9reXRjVl9UV2F5elY4Wlk5TmJZNkdPN25WUjNpRUJkM2phb2VMWWlsYkwwUDJxVm9PUGV3VEhGY2szbm1FOWc?oc=5", "source_name": "Market source", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda (TAK) plans FY2025 IFRS earnings revision after AMITIZA antitrust verdict", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPQWlYWXNHam5saERTLWVpOWItNldKdkJJaXJRVmI3Q0RYQmZSOGhPMWl4eV9obEVSTHd4N0lVLVJodVJDSkROUFRkMnljU3BmWFhyaGZkOVFyLU5DRVVNLXJOUG1kd3pvMjBOcm1FNzNSX1oxQTVMc21XN1F4ZExlZktVWVdibHdTWW9uaTJucVUtVEdyeW5OVDQxaWpHODgzcC11UjRrZzJPZmtESWFheUpwZVpZWmNpTmxvOURXZXQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical : Continuation of the Stock Compensation Plan for Directors and the Stock Grant System for Company Management in Japan in 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNNHZOdThzN0F2YkNLZ3lrNE9OT3luR2ZZV1MzcFlxODB0ODFZZXIzVXl0MVJNRWVyZEVLdFA3Xy1CRXYxQzFXb1NfZUx2ZldES19ObzlIdzZOajVxaHNMenRMYXA2YW5JbU82bkwtdXBVR2ZRZVA1WVJHdmJTWDJhdXh0SGlsMGJfVkZaaF9XNzAzYUQ1LUN4RzNNMGlNU3NsMjgyVEtxNHVXMUpKcTFTdUdBRkdaM1hnMWgtWFdueWZHelZkQVRjdVFiTV9uZFA0dm9NYXltSndkcW1KSjY4eWU1NkFtZw?oc=5", "source_name": "marketscreener.com", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical (TSE:4502) Valuation Check After Recent Share Price Pullback", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQeGp1cEpfNUx4ZjE5Ml9ONWFydUZqV0d4VTlvLWstc1U5YUZIcHFZcTAwbThPTHBxY2liWmVHbmtZVXZiVjl5NldjWUlROUY2WVJiTmJiQms1YzF1X1ZiNjd5NUtacTc1Yk0wc3VuM1g3NjMxdjZOblFfTGlzZWNKUDJiM1E0S1Z1YTZ4dDdJSkdhbjRESmNPOFp5RGJtbERkTTdDWTVWdkxUVTN0MVE?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Takeda Pharmaceutical Company Limited (TAK) One of the Best Japanese Stocks Amid Restructuring Drive?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQRkFWZ3o4c21ET2tVMzVGNDFhVS1OZnhIZU5uOEh5akxTT2JuV0ZvaEtLRl9DNHZBS1VwOVZWNlBnZEdYOVYta0ZnbmNmaUhoVDFURjJqT1QyZnBPWjJzenlmUnc5dGhyeW5NUWN0V1JyTE12WEtaVEluUm8wQ1FwLUdXZVFfU1JFTEhha0lmcXcxaF9hd19jcTZmSzY3N1F5cWlPal9jbGNIajNhbFQ4?oc=5", "source_name": "Market source", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNckpfeDdTSDBxVTFueWdHZHRya2tPcDVKdWxJR005c0Q1MjdNRXE0cG1OalM2LW1yMUxuekZXOHhlRFcydVlibUgwVnNSRkdQd2lRTUhhR0ItVk5ub2loSGFzanNwX1BLLXlpZklYc3RXTWJodDdWNU0wLTd3dXBPOXBCV3VhdGZSb2FzTzk2SmNLTkRfcFJOV3E2YnJwOEFzdjRMQkNROHlxOGwxRVRR?oc=5", "source_name": "Market source", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Takeda Pharmaceutical (TSE:4502) Valuation After Mixed Pipeline News On DNL593 And Zasocitinib", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQU1VkMlNwTmlsYkQ2X3lrWDRrQ2JQQU1jdERabHhCVHZhcVBVNGpnUHJ5dWdJVzVTMXZVSUVDaTJBUExQRkZOSS1ZWjNOTHBqMDM5Y3hGMTJES3AwdU9yU1FQejlRYmI2bGtpNHdVLVZPOEptWGF0d3VLM09CMzFvZTNoSzJHdjc4Z3RVZTZjRlJHQmliVE9xZGV0cGZydzhVRW5uMnlXUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-08T07:00:00+00:00", "published_display": "08 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharmaceutical Company Limited: Takeda Announces Next Steps in its Transformation to Strengthen Competitiveness and Accelerate Future Growth Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgJBVV95cUxQVlhuOWMyU3MybTdKNkN4R0E2WWx5dVZZa3VCSHNzVW9QUHg1b1E3Z3VPNDhWVjJGaXZmeXV5cVk1dnJTVHlhR25pcl9XN2hzdlF0ekJmd0J2Y2duMFhhRVBlSTEzRjVIem51eTVsVkhYcC1MTnhUeFI0M0xFMUpXaXlHLUd0R0ZBWDhiQ3J0UktERDF2bjQxTnN3V1E3VFBIeVBUbmtYQlBsMVBzQmtGYmRKS3JNUUpGenB0d01KY3ZMX2ctcnZkX2FsMi13eXMwMnd3N3loSWtsUjRoZVhaUDBRbXpCYlc2X0cyU2dpSkVXME5RZUN1QTk3WHhhOGtlNWlMZWswQXJNVVBFUzVJbXhNOUtaTXNYaVB1SGZQVS1CM3pxd19WdlU4RWtPRHVjb0E?oc=5", "source_name": "TradingView", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Takeda Pharmaceutical Company Limited (TAK) One of the Best Healthcare Stocks to Buy for 2026?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxPV2EwUkxKSVZNaEJLQ0o0NHFHdFZmQ29LTmt1NklBdnVFTHVueHZRTWRTSktZSk1BM1l6LS1sa1RTTXNnOEYtSUcyZ2JBU1V5a0pjRkRiOF9iN1hWNjRqOFpPalRTN0cydVNfbVM1NnB3MERnYmJWOFFKcmM4eE9aMzBabV9mTGgtUUN0dHpTWXM?oc=5", "source_name": "Market source", "published_at": "2026-01-31T08:00:00+00:00", "published_display": "31 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Takeda Pharmaceutical (TSE:4502) After Recent Pipeline Progress And Share Price Moves", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNc0RhajBSeDY4NDA1N2NqenA4cHBWRHE5Y3ZPWXNSdkplT3ZXNkJFRjZjLW1oX0FWNGZ1Z2VSWXpHYk9ISVpVMXozT1ZuZHRoNHFQaDhRNWYxTG4tUVlCdlJpOGM4RGZyRnhPMlAzMzFPUGVFYWdDUkxFMGNUbU5hQ1dJRnR6MlpiamNwSTdOUQ?oc=5", "source_name": "Market source", "published_at": "2026-01-21T08:00:00+00:00", "published_display": "21 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda: Lack Of Realistic Upside In Japanese Pharma (NYSE:TAK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPckc3aUR3TTRPMjVnQkFKRmxNRVZTQk5XdG41T0tZZnZnaDNERENKemd4dmNpRFhBU1dycV96MTQxVzBidkYyWTlSamVmSmhBQ3FGVGRkY0p2MndhT0Q4UXMwSThfNDBLWTJyWGd2akZZRUNHZGdFUFhoS3pqRGZ5cDFvVVQ5VmE2bHlTemIxcWM5VXhHMWc?oc=5", "source_name": "Seeking Alpha", "published_at": "2025-12-11T08:00:00+00:00", "published_display": "11 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China's Innovent signs cancer therapy deal with Japan's Takeda", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxPWER1VnZpYThnbk1ETFl4TmZwUFZVT2xDTEM1YUNKZDNlTXF4eVlsaFotczliNF9IM2xtNXkzUUgxM2NMcU9xRXNYRGQ5VldvdnJSb09GR2I0N0JCdnU5UTBsYi0tUmcxWGEySFdWZ2lwekRWejZ2Z0o0X2FRSDI0bjJBSERxbjJoQ0tQR3N3TlAyNDJYNEw2ZGFMVHlVamhIQlByZjU0RVQ4Y3prV0hyRVVOdDZVdzhwODRNbEtZYTd2aW8zLWpYeUItbXVFOXF5NFlPYmdVRGl6TF9t?oc=5", "source_name": "Reuters", "published_at": "2025-10-21T07:00:00+00:00", "published_display": "21 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "US biotech Nabla Bio, Japan's Takeda expand AI drug design partnership", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxNWG4zbm9ZM2ZwcGNoSHU5WHFuaUJzNVM2X0JiMFRlRlVMZUNXWWJpajFFVlJURl9meEhKOXBQTDAyQXNGeGk0NEJzX0plX0dFY2pTa2JyN1EtWmxyVG1zc2lKQ2g0TEMwdlZHSGFmbGJLU3dDcUJ0U25qcFkwNFY3elVBMWhkXzlqUmhqNWJCLTY4T0ZxRFd6di1DT1BneV9RM3FHdy1mUms3eElaT0FKSUlwTWdieXFDNDM1NUNTRlpKZDZvaXNsLU4zQ3pVcjZ5RmFKYk5vOA?oc=5", "source_name": "Reuters", "published_at": "2025-10-14T07:00:00+00:00", "published_display": "14 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Japan's Takeda weighs India for global trials to speed up drug launches", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxPbE41eFpTVmEzd2thU0c4Z20zT2lHc1RNMzZiWGlFa3JZNGZuTkdNZi1GZzh5T1pvbjNPTU82dExZczlFUGhNQ3Nmb1MtVTNXa0R6d003TUc1M2pqTWdkcTNGb3AxOHFVSEYzMldyQTVEYmg5bVVSRWhCVVpMYkE4YUpOMVptTEYtWUFrWkdPVDl2TTNOU1ZPRWVVeFFsalpjbHNmemZTZXFzVWJaYkI1UTU4dlp4bjgtOVBSTi1lN3pfbEJtNjVoTTRYVldqUTBH?oc=5", "source_name": "Reuters", "published_at": "2025-08-21T07:00:00+00:00", "published_display": "21 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda Pharm (TAK) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUkFVX3lxTE1UaEZGVUlGS09USng0czlWN3ZkYlVrMWZQd3hxeFk3YmpSODNmM1B5RmZ3TUpuRmgxM0wxdm1LbjlCN3BpbmMzS1F4NTFSYVZibnc?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T01:22:22+00:00", "published_display": "25 Apr 2025 01:22", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Japan's Takeda announces share buyback as profit climbs", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYkFVX3lxTE5jMk5YRTA1NmNQQmVYUTBoOE9JcExjRms0ZDlaNldUYTl5NlNkUHZVaGZ3SmQtS3ZzaWJBbVgtSGM1NGdnc05QR3BGV3VrWkVEb3g0X1c3N0hGX2N0QmY2MGlR?oc=5", "source_name": "nippon.com", "published_at": "2021-10-28T07:00:00+00:00", "published_display": "28 Oct 2021 07:00", "sentiment": "positive", "sentiment_pct": 78, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 76, "total_relevant": 33, "sentiment_summary": {"positive": 9, "negative": 1, "neutral": 23, "score": 55, "total": 33, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 86, "events": [{"event": "general", "label": "Market update", "weight": 15.15, "count": 25}, {"event": "deals", "label": "Deals and strategy", "weight": 2.9, "count": 4}, {"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}], "positive_events": 9, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 5513.0, "latest_week": "2026-07-31", "one_week_move": -2.4, "four_week_move": 2.9, "twelve_week_move": 5.8, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.273445, "market_dynamics_buy_signal": false, "relative_strength": -5.631884, "fair_value_gap": 29.3, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 52.6298, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-2.4% over one week, +2.9% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 66, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 10}, {"label": "simplywall.st", "count": 6}, {"label": "Reuters", "count": 4}, {"label": "Stock Titan", "count": 2}, {"label": "MarketBeat", "count": 1}, {"label": "Morningstar", "count": 1}, {"label": "Yahoo! Finance Canada", "count": 1}, {"label": "TradingKey", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 33}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 25}, {"label": "Deals and strategy", "count": 4}, {"label": "Earnings", "count": 2}, {"label": "Guidance", "count": 1}, {"label": "Capital return", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "86/100 classification confidence."}, {"label": "Company focus", "value": "33", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "6", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-2.4% over one week, +2.9% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "TAK News Today | Why did Takeda Pharmaceutical stock go down today? $TAK"}], "updated_at": "2026-08-06T09:21:56.828306+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}